Yong-Jun Huh - Jul 18, 2024 Form 3 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Director
Signature
/s/ Jennifer Bush, Attorney-in-Fact
Stock symbol
ARTV
Transactions as of
Jul 18, 2024
Transactions value $
$0
Form type
3
Date filed
7/18/2024, 08:02 PM
Next filing
Jul 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ARTV Common Stock 349K Jul 18, 2024 By GC Corp F1
holding ARTV Common Stock 233K Jul 18, 2024 By GC Cell Corporation F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARTV Series A Preferred Stock Jul 18, 2024 Common Stock 667K By GC Corp F1, F3
holding ARTV Series B Preferred Stock Jul 18, 2024 Common Stock 330K By GC Corp F1, F3
holding ARTV Series A Preferred STock Jul 18, 2024 Common Stock 293K By GC Cell Corporation F2, F3
holding ARTV Series B Preferred Stock Jul 18, 2024 Common Stock 62.2K By GC Cell Corporation F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by GC Corp. Mr. Yong-Jun Huh is Chief Executive Officer of GC Corp. GC Corp., a public Korean holdings company, is ultimately controlled by its board of directors, consisting of Mr. Yong-Jun Huh, Huh II-Sup, Park Yong-Tae and Kim Seok-Hwa. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and each disclaims beneficial ownership of all shares held by such entity, except to the extent of any pecuniary interest therein.
F2 The shares are held directly by GC Cell Corporation. Mr. Yong-Jun Huh is Chief Executive Officer of GC Corp. GC Corp., a public Korean holdings company, which is the parent company of GC Cell Corporation and is ultimately controlled by its board of directors, consisting of Mr. Yong-Jun Huh, Huh II-Sup, Park Yong-Tae and Kim Seok-Hwa. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and GC Cell Corporation and each disclaims beneficial ownership of all shares held by such entities, except to the extent of any pecuniary interest therein.
F3 Each share of Series A Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") is convertible into shares of Common Stock of the Issuer on a one-for-one basis without payment of further consideration. Upon the closing of the Issuer's initial public offering, the Preferred Stock will convert into the number of shares of Common Stock of the Issuer shown in column 3. The Preferred Stock has no expiration date.